BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18941250)

  • 21. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
    Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Listeriolysin O, a cytolysin derived from Listeria monocytogenes, inhibits generation of ovalbumin-specific Th2 immune response by skewing maturation of antigen-specific T cells into Th1 cells.
    Yamamoto K; Kawamura I; Tominaga T; Nomura T; Kohda C; Ito J; Mitsuyama M
    Clin Exp Immunol; 2005 Nov; 142(2):268-74. PubMed ID: 16232213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo.
    Fallarino F; Grohmann U; Bianchi R; Vacca C; Fioretti MC; Puccetti P
    J Immunol; 2000 Nov; 165(10):5495-501. PubMed ID: 11067902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel diversity in Th1, Th2 type differentiation of hemagglutinin-specific T cell clones elicited by natural influenza virus infection in three major haplotypes (H-2b,d,k).
    Graham CM; Smith CA; Thomas DB
    J Immunol; 1998 Aug; 161(3):1094-103. PubMed ID: 9686567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients.
    Bellone G; Turletti A; Artusio E; Mareschi K; Carbone A; Tibaudi D; Robecchi A; Emanuelli G; Rodeck U
    Am J Pathol; 1999 Aug; 155(2):537-47. PubMed ID: 10433946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
    Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
    Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
    Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M
    Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.
    Steigerwald-Mullen P; Kurilla MG; Braciale TJ
    J Virol; 2000 Aug; 74(15):6748-59. PubMed ID: 10888613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer.
    Song K; Chang Y; Prud'homme GJ
    Gene Ther; 2000 Mar; 7(6):481-92. PubMed ID: 10757021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomas.
    Schepers K; Toebes M; Sotthewes G; Vyth-Dreese FA; Dellemijn TA; Melief CJ; Ossendorp F; Schumacher TN
    J Immunol; 2002 Sep; 169(6):3191-9. PubMed ID: 12218137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0.
    Barnard A; Mahon BP; Watkins J; Redhead K; Mills KH
    Immunology; 1996 Mar; 87(3):372-80. PubMed ID: 8778021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
    Hiraoka N; Onozato K; Kosuge T; Hirohashi S
    Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of IFN in respiratory syncytial virus pathogenesis.
    Durbin JE; Johnson TR; Durbin RK; Mertz SE; Morotti RA; Peebles RS; Graham BS
    J Immunol; 2002 Mar; 168(6):2944-52. PubMed ID: 11884466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells.
    Adurthi S; Mukherjee G; Krishnamurthy H; Sudhir K; Bafna UD; Umadevi K; Jayshree RS
    Int J Gynecol Cancer; 2012 Sep; 22(7):1130-7. PubMed ID: 22872166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoregulation in pancreatic cancer patients.
    Plate JM; Shott S; Harris JE
    Cancer Immunol Immunother; 1999 Aug; 48(5):270-9. PubMed ID: 10478644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hantaan virus infection induces both Th1 and ThGranzyme B+ cell immune responses that associated with viral control and clinical outcome in humans.
    Ma Y; Yuan B; Zhuang R; Zhang Y; Liu B; Zhang C; Zhang Y; Yu H; Yi J; Yang A; Jin B
    PLoS Pathog; 2015 Apr; 11(4):e1004788. PubMed ID: 25836633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dehydroepiandrosterone modulates T-cell response after major abdominal surgery.
    Pratschke S; von Dossow-Hanfstingl V; Dietz J; Schneider CP; Tufman A; Albertsmeier M; Winter H; Angele MK
    J Surg Res; 2014 Jun; 189(1):117-25. PubMed ID: 24650456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.